Paydirt
RD
Insider

Robert M Davis

Chairman, CEO & President

Robert M Davis (Chairman, CEO & President) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Merck & Co., Inc. (MRK). The largest single filing was $5.6M of MRK (47,434 sh across 2 lots, as filed), executed Feb 4.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.6M
shares × price, as filed
Last traded
Feb 4
Filed Feb 6

Median ADV $1.4B across their filed names

Open performance→
Volume by month
$5.6M$2.8M$0Oct 2024Apr 2025Oct 2025Apr 2026Feb 2026 · sells $5.6M
Buys $0 Sells $5.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
MRK Merck & Co., Inc. MRK · 0 buys · 1 sell 1 filing
Recent filings
MRKSALE Merck & Co., Inc. View filing → $5.6M
47,434 sh across 2 lots
Exec Feb 4
Filed Feb 6 · 5:30 PM ET